adenosine has been researched along with Central European Encephalitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Clercq, E; Eyer, L; Fojtíková, M; Haviernik, J; Nencka, R; Růžek, D; Širmarová, J; Štefánik, M; Zouharová, D | 1 |
| De Clercq, E; de Lamballerie, X; Driouich, JS; Eyer, L; Gould, EA; Haviernik, J; Nougairède, A; Ruzek, D; Uhlířová, M; Valdés, JJ; Zouharová, D | 1 |
2 other study(ies) available for adenosine and Central European Encephalitis
| Article | Year |
|---|---|
Antiviral activity of the adenosine analogue BCX4430 against West Nile virus and tick-borne flaviviruses.
Topics: Adenine; Adenosine; Animals; Antiviral Agents; Cell Line; Cell Survival; Chlorocebus aethiops; Culicidae; Dose-Response Relationship, Drug; Encephalitis Viruses, Tick-Borne; Encephalitis, Tick-Borne; Flavivirus; Purine Nucleosides; Pyrrolidines; Swine; Tick-Borne Diseases; Ticks; Vero Cells; Virus Replication; West Nile virus | 2017 |
An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice.
Topics: Adenine; Adenosine; Alleles; Amino Acid Substitution; Animals; Antiviral Agents; Cell Line; Disease Models, Animal; Drug Resistance, Microbial; Drug Resistance, Viral; Encephalitis Viruses, Tick-Borne; Encephalitis, Tick-Borne; Genotype; Mice; Mutation; Pyrrolidines; Viral Nonstructural Proteins | 2019 |